Overview

Study of OTO-104 in Subjects With Unilateral Meniere's Disease

Status:
Terminated
Trial end date:
2017-09-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of OTO-104 for the treatment of Meniere's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Otonomy, Inc.